These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 16343437)

  • 1. Splicing variant of Cdc42 interacting protein-4 disrupts beta-catenin-mediated cell-cell adhesion: expression and function in renal cell carcinoma.
    Tsuji E; Tsuji Y; Fujiwara T; Ogata S; Tsukamoto K; Saku K
    Biochem Biophys Res Commun; 2006 Jan; 339(4):1083-8. PubMed ID: 16343437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cdc42-Interacting Protein 4 Represses E-Cadherin Expression by Promoting β-Catenin Translocation to the Nucleus in Murine Renal Tubular Epithelial Cells.
    Xu C; Zhou Q; Liu L; Liu P; Pei G; Zeng R; Han M; Xu G
    Int J Mol Sci; 2015 Aug; 16(8):19170-83. PubMed ID: 26287173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and genetic analysis of human and mouse activated Cdc42 interacting protein-4 isoforms.
    Wang L; Rudert WA; Grishin A; Dombrosky-Ferlan P; Sullivan K; Deng X; Whitcomb D; Corey S
    Biochem Biophys Res Commun; 2002 May; 293(5):1426-30. PubMed ID: 12054674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a CIP4 PKA phosphorylation site involved in the regulation of cancer cell invasiveness and metastasis.
    Tonucci FM; Almada E; Borini-Etichetti C; Pariani A; Hidalgo F; Rico MJ; Girardini J; Favre C; Goldenring JR; Menacho-Marquez M; Larocca MC
    Cancer Lett; 2019 Oct; 461():65-77. PubMed ID: 31319138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of beta-catenin in renal cell carcinoma.
    Zang T; Zhuang L; Zhang Z; Xin D; Guo Y
    Chin Med J (Engl); 2001 Feb; 114(2):152-4. PubMed ID: 11780196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
    Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R
    Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations.
    Bilim V; Kawasaki T; Katagiri A; Wakatsuki S; Takahashi K; Tomita Y
    Clin Cancer Res; 2000 Feb; 6(2):460-6. PubMed ID: 10690524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic oxidative stress causes amplification and overexpression of ptprz1 protein tyrosine phosphatase to activate beta-catenin pathway.
    Liu YT; Shang D; Akatsuka S; Ohara H; Dutta KK; Mizushima K; Naito Y; Yoshikawa T; Izumiya M; Abe K; Nakagama H; Noguchi N; Toyokuni S
    Am J Pathol; 2007 Dec; 171(6):1978-88. PubMed ID: 18055543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.
    Breault JE; Shiina H; Igawa M; Ribeiro-Filho LA; Deguchi M; Enokida H; Urakami S; Terashima M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):557-64. PubMed ID: 15701841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIF-2alpha enhances beta-catenin/TCF-driven transcription by interacting with beta-catenin.
    Choi H; Chun YS; Kim TY; Park JW
    Cancer Res; 2010 Dec; 70(24):10101-11. PubMed ID: 21159632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Cdc42-interacting protein 4 (CIP4) impairs osteosarcoma tumor progression.
    Koshkina NV; Yang G; Kleinerman ES
    Curr Cancer Drug Targets; 2013 Jan; 13(1):48-56. PubMed ID: 22920438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diaphanous-related formin DAAM1 collaborates with the Rho GTPases RhoA and Cdc42, CIP4 and Src in regulating cell morphogenesis and actin dynamics.
    Aspenström P; Richnau N; Johansson AS
    Exp Cell Res; 2006 Jul; 312(12):2180-94. PubMed ID: 16630611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1QBP suppresses cell adhesion and metastasis of renal carcinoma cells.
    Wang Y; Fu D; Su J; Chen Y; Qi C; Sun Y; Niu Y; Zhang N; Yue D
    Sci Rep; 2017 Apr; 7(1):999. PubMed ID: 28428626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PML is a target gene of beta-catenin and plakoglobin, and coactivates beta-catenin-mediated transcription.
    Shtutman M; Zhurinsky J; Oren M; Levina E; Ben-Ze'ev A
    Cancer Res; 2002 Oct; 62(20):5947-54. PubMed ID: 12384561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling.
    Kojima T; Shimazui T; Hinotsu S; Joraku A; Oikawa T; Kawai K; Horie R; Suzuki H; Nagashima R; Yoshikawa K; Michiue T; Asashima M; Akaza H; Uchida K
    Oncogene; 2009 Jan; 28(2):297-305. PubMed ID: 18931698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression.
    Copland JA; Luxon BA; Ajani L; Maity T; Campagnaro E; Guo H; LeGrand SN; Tamboli P; Wood CG
    Oncogene; 2003 Sep; 22(39):8053-62. PubMed ID: 12970754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma.
    Ueno K; Hirata H; Majid S; Chen Y; Zaman MS; Tabatabai ZL; Hinoda Y; Dahiya R
    Mol Carcinog; 2011 Jun; 50(6):449-57. PubMed ID: 21268126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CIP4 is a new ArgBP2 interacting protein that modulates the ArgBP2 mediated control of WAVE1 phosphorylation and cancer cell migration.
    Roignot J; Taïeb D; Suliman M; Dusetti NJ; Iovanna JL; Soubeyran P
    Cancer Lett; 2010 Feb; 288(1):116-23. PubMed ID: 19631450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma.
    Hirata H; Hinoda Y; Nakajima K; Kawamoto K; Kikuno N; Ueno K; Yamamura S; Zaman MS; Khatri G; Chen Y; Saini S; Majid S; Deng G; Ishii N; Dahiya R
    Int J Cancer; 2011 Apr; 128(8):1793-803. PubMed ID: 20549706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laminin alpha1 chain in human renal cell carcinomas and integrin-mediated adhesion of renal cell carcinoma cells to human laminin isoforms.
    Rissanen J; Korhonen M; Lehto VP; Virtanen I
    J Pathol; 2003 Jun; 200(2):157-67. PubMed ID: 12754736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.